Close this search box.

We are creating some awesome events for you. Kindly bear with us.

India, UK ink MoU for research on affordable cancer technology

India’s Department of Biotechnology and the Cancer Research UK have inked a Memorandum of Understanding (MoU) for an India-UK Cancer Research Initiative.

The MoU was signed earlier this week in New Delhi at the Inaugural Researchers’ Summit, held from 14 to 16 November.

The initiative is a collaborative five-year bilateral research programme by the Department of Biotechnology (DBT) under the Indian Ministry of Science & Technology, and the Cancer Research UK (CRUK).

The Chief Information Officer (CIO) of the organisation, Ms Tiffany Hall said that technology is being invested in and prioritised at Cancer Research UK like never before. She said the newly created team are focussed on driving forward the sort of cutting-edge solutions that are vital to its continued growth and development.

The India-UK initiative will focus on developing affordable approaches to cancer treatment. Both Cancer Research UK and the Department of Biotechnology will invest GBP £5 million around (US $6.4 million) each in the 5-year pilot and seek further investment from other potential funding partners.

An official press release said that the India-UK Cancer Research Initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer. It plans to bring together leading Indian and UK experts across clinical research, demographic research, and new technologies and physical sciences.

The initiative will provide funding to develop new research alliances and has the potential make significant progress in cancer treatment.

Earlier this year, during his visit to the UK, Indian Prime Minister Narendra Modi said that the two nations will share their experience and knowledge to tackle global challenges. This £10 million (around US $12.8 million) bilateral research initiative will focus on low-cost approaches to cancer.

The release said the India-UK Cancer Research Initiative will provide a catalysing platform for scientists and researchers in the UK and India to co-create solutions for affordable cancer care that improves cancer outcomes around the world.

Cancer Research UK is the world’s largest cancer charity that is dedicated to saving lives through research. According to its website, huge change is happening right now as the organisation’s award-winning Digital and Technology teams join forces to create a leading-edge Tech team that’s significantly ahead of the industry on innovations and solutions in the digital space.

The Department of Biotechnology’s priority is to apply science to solving complex challenges that benefit all humanity and will partner with Cancer Research UK to support research across all stages of cancer from prevention to cure to address the formidable challenge of cancer.

Mr Nick Grant, Cancer Research UK’s Executive Director of international partnerships, said that no country escapes the impact of cancer. Millions around the world diagnosed with the disease every year and the two sides need to bring together the brightest scientific minds across the world and break down barriers to address the challenge of cancer globally.

The Inaugural Researchers’ Summit facilitated knowledge sharing and communication among scientists, researchers, epidemiologists, clinicians, public health professionals, and industry in the field of oncology.

A board of advisors including five cancer experts each from India and UK will oversee the research phases of the initiative. Prof David Hunter of the University of Oxford and Dr CS Pramesh of the Tata Memorial Hospital will serve respectively as Chair and Co-chair of the India-UK Cancer Research Initiative’s Advisory Panel.

The initiative will provide an opportunity to tackle the global epidemic of cancer by opening new pathways for international knowledge exchange and research base.

The research outcomes of this partnership will aid cancer prevention, control and management in the long run.

The release said the joint investment by both countries in this initiative is a testament to the emerging consensus that solutions to affordable cancer care lie in building strategic and evidence-based research partnerships that benefit the global cancer community.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.